Treatment of glial tumors with glutamate antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/439 (2006.01) A61K 31/00 (2006.01) A61K 31/136 (2006.01) A61K 31/195 (2006.01) A61K 31/4747 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2457011

The present invention relates to a method of treating glial tumors in a subject, which includes providing a glutamate antagonist or a NMDA receptor antagonist and administering the glutamate antagonist or NMDA receptor antagonist to a subject with a glial tumor of the brain or spinal cord under conditions effective to treat the glial tumor.

L'invention concerne une méthode de traitement de tumeurs gliales chez un sujet, consistant à fournir un antagoniste du glutamate ou un antagoniste du récepteur NMDA et à administrer ledit antagoniste du glutamate ou antagoniste du récepteur NMDA à un sujet présentant une tumeur cérébrale ou une tumeur de la moëlle épinière, dans des conditions efficaces pour traiter ladite tumeur gliale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of glial tumors with glutamate antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of glial tumors with glutamate antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glial tumors with glutamate antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1376907

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.